BRIDGEBIO PHARMA INC (BBIO) Institutional Ownership and Insiders Activity

BRIDGEBIO PHARMA INC (BBIO) is widely held by institutional investors, with 3 tracked firms reporting positions valued at approximately $909.99M based on SEC Form 13F filings for the quarter ended March 31, 2026.

Viking Global Investors is the largest disclosed holder, reporting approximately $879.42M in BBIO holdings in its latest filing.

Institutional ownership among tracked investors remains highly concentrated, with Viking Global Investors representing the majority of disclosed value.